期刊
EUROPEAN JOURNAL OF CELL BIOLOGY
卷 88, 期 12, 页码 731-742出版社
ELSEVIER GMBH, URBAN & FISCHER VERLAG
DOI: 10.1016/j.ejcb.2009.07.004
关键词
ERK; Endothelium; Cytokines; Th1-response; Synergism
类别
资金
- Tuscany Regional Study On Rosiglitazone (TRESOR)
Tumor necrosis factor alpha (TNF alpha) and interferon gamma (IFN gamma) are among the most potent cytokines involved in orchestrating the inflammation response. The molecular mechanisms implicated in the synergism between cytokines are still poorly characterized. We demonstrate that both cytokines dose-dependently stimulate IFN gamma-inducible-protein-of-10-kDa (IP-10) secretion in human microvascular endothelial cells (HMEC-1), showing a potent synergism which is not restricted to IP-10, but is also evident for monokine-induced-by-IFN gamma (MIG) and IL-6 secretion. Immunofluorescence analysis reveals that TNF alpha and IFN gamma converge on a rapid phosphorylation of ERK, which however results in a different subcellular compartmentalization of the activated enzyme in response to the two cytokines. Differences in the subcellular recruitment of ERK in response to IFN gamma and TNF alpha are responsible for generating different ERK downstream signaling, which can thus synergize on the secretion of IP-10 as well as of other cytokines/chemokines. The importance of ERK activation in mediating the synergism of the two cytokines is further confirmed by the inhibitory effect of the anti-diabetic drug rosiglitazone and ERK blockers on IP-10, MIG and IL-6 secretion. A further mechanism of synergism involving the reciprocal upregulation of TNF alpha-R11 and of IFN gamma-R, in response to IFN gamma and TNF alpha, respectively, was revealed by flow cytometry and quantitative real time RT-PCR analysis. (C) 2009 Elsevier GmbH. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据